Genomics Revolution Meets Regulatory Evolution: Why Personalized Medicine Is Taking So Long

FDA Commissioner Hamburg notes challenges of changing regulatory models to advance personalized medicine during AAAS/FDLI colloquium. But "we will establish a clear and illuminated pathway for product approval."